231 related articles for article (PubMed ID: 34830354)
1. Metalloproteinases in Endometrial Cancer-Are They Worth Measuring?
Michalczyk K; Cymbaluk-Płoska A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830354
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study.
Graesslin O; Cortez A; Fauvet R; Lorenzato M; Birembaut P; Daraï E
Ann Oncol; 2006 Apr; 17(4):637-45. PubMed ID: 16407419
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Tunuguntla R; Ripley D; Sang QX; Chegini N
Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
[TBL] [Abstract][Full Text] [Related]
4. [Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study].
Bogusiewicz M; Stryjecka-Zimmer M; Rechberger T
Ginekol Pol; 2007 May; 78(5):366-72. PubMed ID: 17867327
[TBL] [Abstract][Full Text] [Related]
5. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
6. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Graesslin O; Cortez A; Uzan C; Birembaut P; Quereux C; Daraï E
Int J Gynecol Cancer; 2006; 16(5):1911-7. PubMed ID: 17009991
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
8. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review.
Padežnik T; Oleksy A; Cokan A; Takač I; Sobočan M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982551
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
[TBL] [Abstract][Full Text] [Related]
11. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
12. Involvement of matrix metalloproteinases and their inhibitors in endometrial extracellular matrix turnover in Chlamydia trachomatis-infected recurrent spontaneous aborters.
Singh N; Prasad P; Das B; Rastogi S
Pathog Dis; 2017 Jan; 75(1):. PubMed ID: 28115359
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Wang XH; Liu YN; Tian K; Yao CX; Li LM; Zheng YQ; Shi ZM
J Biol Regul Homeost Agents; 2017; 31(4):879-887. PubMed ID: 29254290
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.
Jedryka M; Chrobak A; Chelmonska-Soyta A; Gawron D; Halbersztadt A; Wojnar A; Kornafel J
Int J Gynecol Cancer; 2012 Oct; 22(8):1303-9. PubMed ID: 22964525
[TBL] [Abstract][Full Text] [Related]
17. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.
Park YH; Ryu HS; Choi DS; Chang KH; Park DW; Min CK
Int J Gynecol Cancer; 2003; 13(1):53-60. PubMed ID: 12631221
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
20. Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis.
Huang Y; Shen L; Cai A; Xiao J
J Tradit Chin Med; 2015 Oct; 35(5):571-6. PubMed ID: 26591688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
